The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2023 | Key highlights from BTOG 2023
Corinne Faivre-Finn, FRCR, MD, PhD, The University of Manchester, & The Christie NHS, Manchester, UK, reflects on her main highlights from the British Thoracic Oncology Group (BTOG) Annual Conference 2023, including a thought-provoking presentation on the management of complicated lung cancer cases. This talk focused on patients with stage III non-small cell lung cancer, as well as the extra considerations that must be taken for those that are elderly or frail. Dr Faivre-Finn also discusses the role of radiotherapy and immunotherapy in the consolidation setting. This interview took place BTOG 2023 in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
